Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Disorders”

552 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 552 results

Testing effectiveness (Phase 2)Looking for participantsNCT03582800
What this trial is testing

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

Who this might be right for
Systemic SclerosisDermatomyositisiPPSD2
University Hospital, Limoges 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Large-scale testing (Phase 3)UnknownNCT05172817
What this trial is testing

Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients

Who this might be right for
PharmacokineticsSafetyEfficacy+1 more
Institute for Developing Science and Health Initiatives, Bangladesh 200
Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26
Post-approval studies (Phase 4)Study completedNCT03055494
What this trial is testing

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Early research (Phase 1)Active Not RecruitingNCT07078695
What this trial is testing

A Trial of SHR-1139 in Healthy Volunteers

Who this might be right for
Psoriasis
Atridia Pty Ltd. 24
Early research (Phase 1)Study completedNCT06929039
What this trial is testing

Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA
Kashiv BioSciences, LLC 300
Not applicableStudy completedNCT04781439
What this trial is testing

The Effect of Early Switching From Intravenous to Oral Antibiotics Therapy

Who this might be right for
Skin and Subcutaneous Tissue Infection
Gia Dinh People Hospital 210
Large-scale testing (Phase 3)Study completedNCT01605136
What this trial is testing

Phase III Confirmatory Study in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Not applicableUnknownNCT04499001
What this trial is testing

Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs

Who this might be right for
Arthritis, RheumatoidSpondyloarthritisBiological Therapy
Hôpital Cochin 60
Testing effectiveness (Phase 2)Study completedNCT01987609
What this trial is testing

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Who this might be right for
Psoriasis
Tissa Hata, MD 7
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Enrolling By InvitationNCT07223138
What this trial is testing

Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 1,560
Not applicableLooking for participantsNCT07489248
What this trial is testing

Multimodal Ultrasound for Differentiating Lymphedema and Lipedema

Who this might be right for
LymphedemaLipedema
Kayseri City Hospital 75
Testing effectiveness (Phase 2)Study completedNCT01382589
What this trial is testing

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo

Who this might be right for
Vitiligo
Clinuvel Pharmaceuticals Limited 15
Not applicableNot Yet RecruitingNCT07395674
What this trial is testing

Subcutaneous Dexpanthenol Administration and Wound Epithelialization

Who this might be right for
Chronic WoundsDiabetic Foot UlcerVenous Leg Ulcers+1 more
Dilara CANBAY OZDEMIR 40
Large-scale testing (Phase 3)Study completedNCT01964391
What this trial is testing

Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 174
Next Page